Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group.
Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Phillips M, Sokal M, Gray E, McKeever P, Oakhill A. Mann JR, et al. Med Pediatr Oncol. 1998 Apr;30(4):217-27. doi: 10.1002/(sici)1096-911x(199804)30:4<217::aid-mpo3>3.0.co;2-j. Med Pediatr Oncol. 1998. PMID: 9473756 Review.
The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, Gray E, McKeever P, Hale J, Bailey S, Oakhill A. Mann JR, et al. J Clin Oncol. 2000 Nov 15;18(22):3809-18. doi: 10.1200/JCO.2000.18.22.3809. J Clin Oncol. 2000. PMID: 11078494 Clinical Trial.
Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG).
White L, Kellie S, Gray E, Toogood I, Waters K, Lockwood L, Macfarlane S, Johnston H. White L, et al. J Pediatr Hematol Oncol. 1998 Mar-Apr;20(2):125-30. doi: 10.1097/00043426-199803000-00007. J Pediatr Hematol Oncol. 1998. PMID: 9544162 Clinical Trial.
Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones.
Denisenko E, de Kock L, Tan A, Beasley AB, Beilin M, Jones ME, Hou R, Muirí DÓ, Bilic S, Mohan GRKA, Salfinger S, Fox S, Hmon KPW, Yeow Y, Kim Y, John R, Gilderman TS, Killingbeck E, Gray ES, Cohen PA, Yu Y, Forrest ARR. Denisenko E, et al. Among authors: gray es. Nat Commun. 2024 Apr 3;15(1):2860. doi: 10.1038/s41467-024-47271-y. Nat Commun. 2024. PMID: 38570491 Free PMC article.
Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy.
Abed A, Beasley AB, Reid AL, Law N, Calapre L, Millward M, Lo J, Gray ES. Abed A, et al. Among authors: gray es. ESMO Open. 2023 Dec;8(6):102066. doi: 10.1016/j.esmoop.2023.102066. Epub 2023 Nov 22. ESMO Open. 2023. PMID: 37995426 Free PMC article.
Detection of metastases using circulating tumour DNA in uveal melanoma.
Beasley AB, de Bruyn DP, Calapre L, Al-Ogaili Z, Isaacs TW, Bentel J, Reid AL, Dwarkasing RS, Pereira MR, Khattak MA, Meniawy TM, Millward M, Brosens E, de Klein A, Chen FK, Kiliҫ E, Gray ES. Beasley AB, et al. Among authors: gray es. J Cancer Res Clin Oncol. 2023 Nov;149(16):14953-14963. doi: 10.1007/s00432-023-05271-3. Epub 2023 Aug 22. J Cancer Res Clin Oncol. 2023. PMID: 37608028 Free PMC article.
171 results